Association between first-trimester maternal serum pregnancy-associated plasma protein-a and obstetric complications

Prenatal Diagnosis

Volumn 33, Issue 9, 2013, Pages 839-847

  D'Antonio, Francesco ^a   Rijo, Claudia ^a   Thilaganathan, Basky ^a   Akolekar, Ranjit ^a   Khalil, Asma ^a   Papageourgiou, Aris ^a   Bhide, Amar ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY PREECLAMPSIA; ECLAMPSIA; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMALL FOR DATE INFANT;

ADULT; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREMATURE BIRTH; RETROSPECTIVE STUDIES;

EID: 84883447836     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4141     Document Type: Article

References (58)

1. Goetzl L. Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy. Clin Lab Med 2010;30:613-28.
2. Stout MJ, Goetzinger KR, Tuuli MG, et al. First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth. Placenta 2013;34:14-9.
3. Goetzinger KR, Cahill AG, Kemna J, et al. First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics. Prenat Diagn 2012;32:1002-7.
4. Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
5. Mikolajczyk RT, Zhang J, Betran AP, et al. A global reference for fetal-weight and birthweight percentiles. Lancet 2011;37:1855-61.
6. Poon LC, Maiz N, Valencia C, et al. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33:23-33.
7. Prefumo F, Canini S, Crovo A, et al. Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A). Hum Reprod 2006;21:3019-21.
8. Jakobsen TR, Clausen FB, Rode L, et al. Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA. Transfusion 2013. doi: 10.1111/trf.12073.
9. Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8-15.
10. Di Lorenzo G, Ceccarello M, Cecotti V, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012;33:495-501.
11. Moslemi Zadeh N, Naghshvar F, Peyvandi S, et al. PP13 and PAPP-A in the first and second trimesters: predictive factors for preeclampsia? ISRN Obstet Gynecol 2012;2012:26, 3871.
12. Saruhan Z, Ozekinci M, Simsek M, Mendilcioglu I. Association of first trimester low PAPP-A levels with adverse pregnancy outcomes. Clin Exp Obstet Gynecol 2012;39:225-8.
13. Ranta JK, Raatikainen K, Romppanen J, et al. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Eur J Obstet Gynecol Reprod Biol 2011 Jul;157(1):48-52.
14. Youssef A, Righetti F, Morano D, et al. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11+0 to 13+6weeks in the prediction of late (>34weeks) pre-eclampsia. Prenat Diagn 2011;31:1141-6.
15. Odibo AO, Zhong Y, Goetzinger KR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta 2011;32:598-602.
16. Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13weeks. Prenat Diagn 2011;31:66-74.
17. Poon L, Akolekar R, Lachmann R, et al. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13weeks. Ultrasound Obstet Gynecol 2010;35:662-70.
18. Huang T, Hoffman B, Meschino W, et al. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn 2010;30:471-477.
19. Zhong Y, Bradshaw R, Stanley AP, Odibo AO. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein A and human chorionic gonadotropin and adverse pregnancy outcomes. Am J Perinatol 2011;28:347-54.
20. Audibert F, Boucoiran I, An N, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010;203:383.e1-8.
21. Dane B, Dane C, Kiray M, et al. Correlation between first-trimester maternal serum markers, second-trimester uterine artery Doppler indices and pregnancy outcome. Gynecol Obstet Invest 2010;70:126-31.
22. Conserva V, Signaroldi M, Mastroianni C, et al. Distinction between fetal growth restriction and small for gestational age newborn weight enhances the prognostic value of low PAPP-A in the first trimester. Prenat Diagn 2010;30:1007-9.
23. Hedley PL, Placing S, Wøjdemann K, et al. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia. Prenat Diagn 2010;30:103-9.
24. Uccella S, Colombo GF, Bulgheroni CM, et al. First-trimester maternal serum screening and the risk for fetal distress during labor. Am J Obstet Gynecol 2009;201:166.e1-6.
25. Brameld KJ, Dickinson JE, O'Leary P et al. First trimester predictors of adverse pregnancy outcomes. Aust NZJ Obstet Gynaecol 2008;48:529-35.
26. Spencer K, Cowans NJ, Nicolaides KH. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008;28:7-10.
27. Kang JH, Farina A, Park JH, et al. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 2008;28:704-9.
28. Spencer CA, Allen VM, Flowerdew G, et al. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn 2008;28:1029-36.
29. Canini S, Prefumo F, Pastorino D, et al. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008;89:174-8.
30. Pilalis A, Souka AP, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007;29:135-40.
31. Spencer K, Cowans NJ, Chefetz I, et al. First trimester maternal serum PP-13, PAPP-A and second-trimester uterine Doppler pulsatility as a marker of pre-eclampsia, Ultrasound Obstet Gynecol 2007;29:128-134.
32. Zwahlen M, Gerber S, Bersinger NA. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels. Gynecol Obstet Invest 2007;63:15-21.
33. Spencer K, Yu CK, Cowans NJ, et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005;25:949-53.
34. Kavak ZN, Basgul A, Elter K, et al. The efficacy of first-trimester PAPP-A and free beta hCG levels for predicting adverse pregnancy outcome. J Perinat Med 2006;34:145-8.
35. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446-51.
36. Yaron Y, Heifetz S, Ochshorn Y, et al. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778-82.
37. Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, pre eclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762-7.
38. Ong CY, Liao AW, Spencer K, et al. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107:1265-70.
39. Carbone JF, Tuuli MG, Bradshaw R, et al. Efficiency of first-trimester growth restriction and low pregnancy-associated plasma protein-A in predicting small for gestational age at delivery. Prenat Diagn 2012;32:724-9.
40. Goetzinger KR, Singla A, Gerkowicz S, et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 2009;201:412.e1-6.
41. Scott F, Coates A, McLennan A. Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels. Aust N Z J Obstet Gynaecol 2009;49:258-62.
42. Montanari L, Alfei A, Albonico G, et al. The impact of first-trimester serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A on the diagnosis of fetal growth restriction and small for gestational age infant. Fetal Diagn Ther 2009;25:130-5.
43. Peterson SE, Simhan HN. First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. Am J Obstet Gynecol 2008;198:e43-5.
44. Leung TY, Sahota DS, Chan LW, et al. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol 2008;31:10-4.
45. Spencer K, Cowans NJ, Avgidou K, et al. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008;31:15-9.
46. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27:264-71.
47. Krantz D, Goetzl L, Simpson JL, et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452-8.
48. Tul N, Pusenjak S, Osredkar J, et al. Predicting complications of pregnancy with first-trimester maternal serum free-beta hCG, PAPP-A and inhibin-A. Prenat Diagn 2003;23:990-6.
49. Kwik M, Morris J. Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 2003;43:438-42.
50. Poon LC, Syngelaki A, Akolekar R, et al. Combined screening for preeclampsia and small for gestational age at 11-13weeks. Fetal Diagn Ther 2013;33:16-27.
51. Kirkegaard I, Henriksen TB, Tørring N, Uldbjerg N. PAPP-A and free β-hCG measured prior to 10weeks is associated with preterm delivery and small-for-gestational-age infants. Prenat Diagn 2011;31:171-5.
52. Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol 2011;37:341-7.
53. Karagiannis G, Akolekar R, Sarquis R, et al. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13weeks. Fetal Diagn Ther 2011;29:148-54.
54. Pihl K, Larsen T, Krebs L, Christiansen M. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn 2008;28:1131-5.
55. Pihl K, Sørensen TL, Nørgaard-Pedersen B, et al. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women. Prenat Diagn 2008;28:247-53.
56. Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, pre eclampsia, and stillbirth. J Clin Endocrinol Metab 2002;87:1762-7.
57. Barrett SL, Bower C, Hadlow NC. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn 2008;28:28-35.
58. Marttala J, Peuhkurinen S, Laitinen P, et al. Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths. Acta Obstet Gynecol Cand 2010;89:1226-8.